A systematic review of validated methods for identifying ventricular arrhythmias using administrative and claims data

被引:68
作者
Tamariz, Leonardo [1 ,3 ]
Harkins, Thomas [2 ]
Nair, Vinit [2 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA
[2] Humana Inc, Competit Hlth Analyt, Miami, FL USA
[3] Vet Affairs Med Ctr, Dept Med, Miami, FL 33125 USA
关键词
Validity; ventricular arrhythmias; international classification of diseases; medical record; SUDDEN CARDIAC DEATH; RISK; CISAPRIDE; USERS; EVENTS;
D O I
10.1002/pds.2340
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Drug-induced pro-arrhythmia is a serious and unexpected event. Large administrative and claims databases can potentially identify drugs or interactions leading to cardiac arrhythmias. The purpose of this study is to evaluate the evidence supporting the validity of algorithms or codes to identify ventricular arrhythmias using administrative and claims data. Methods A search of MEDLINE database is supplemented by manual searches of bibliographies of key relevant articles. We selected all studies in which an administrative and claims data algorithm or code was validated against a medical record. We report the positive predictive value (PPV) for ICD-9 codes compared to medical records. Results Our search strategy yielded 664 studies, of which only seven met our eligibility criteria. Two additional studies were identified by peer reviewers. The most commonly included databases were Medicare and Medicaid, and the most commonly evaluated ICD-9 codes were 426. x and 427. x. The individual use of ICD-9 codes 427. x yielded a high PPV (78%-100%). The highest PPV was seen when both ICD-9 codes 427. x and 798. x were used (92%). The same codes yielded the highest PPV when found in the principal diagnosis position (100%). Conclusions The use of ICD-9 codes 427. x, alone or in combination with code 798. x, in the principal position is appropriate for the identification of ventricular arrhythmias in administrative and claims databases. Copyright (C) 2012 John Wiley & Sons, Ltd.
引用
收藏
页码:148 / 153
页数:6
相关论文
共 16 条
  • [1] Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned
    Carnahan, Ryan M.
    Moores, Kevin G.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 82 - 89
  • [2] A computer case definition for sudden cardiac death
    Chung, Cecilia P.
    Murray, Katherine T.
    Stein, C. Michael
    Hall, Kathi
    Ray, Wayne A.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (06) : 563 - 572
  • [3] Pharmacovigilance and the Null Hypothesis Do We do Much for Public Health?
    Edwards, I. Ralph
    Isah, Ambrose
    [J]. DRUG SAFETY, 2011, 34 (02) : 93 - 96
  • [4] Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States
    Enger, C
    Cali, C
    Walker, AM
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (06) : 477 - 486
  • [5] Hanrahan John P., 1995, Annals of Epidemiology, V5, P201, DOI 10.1016/1047-2797(94)00039-V
  • [6] Drug-Induced Arrhythmia
    Heist, E. Kevin
    Ruskin, Jeremy N.
    [J]. CIRCULATION, 2010, 122 (14) : 1426 - 1435
  • [7] Cisapride and ventricular arrhythmia
    Hennessy, Sean
    Leonard, Charles E.
    Newcomb, Craig
    Kimmel, Stephen E.
    Bilker, Warren B.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (03) : 375 - 385
  • [8] Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data
    Hennessy, Sean
    Leonard, Charles E.
    Freeman, Cristin P.
    Deo, Rajat
    Newcomb, Craig
    Kimmel, Stephen E.
    Strom, Brian L.
    Bilker, Warren B.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (06) : 555 - 562
  • [9] Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995
    McDonald, KM
    Hlatky, MA
    Saynina, O
    Geppert, J
    Garber, AM
    McClellan, MB
    [J]. AMERICAN HEART JOURNAL, 2002, 144 (03) : 413 - 421
  • [10] Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes - The MERLIN-TIMI 36 randomized trial
    Morrow, David A.
    Scirica, Benjamin M.
    Karwatowska-Prokopczuk, Ewa
    Murphy, Sabina A.
    Budaj, Andrzej
    Varshavsky, Sergei
    Wolff, Andrew A.
    Skene, Allan
    McCabe, Carolyn H.
    Braunwald, Eugene
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (16): : 1775 - U3